Global Oocyte Cryopreservation Market Strategic Research Report

Scope of the Report

The global Oocyte Cryopreservation market size is predicted to grow from US$ 107 million in 2025 to US$ 277 million in 2032; it is expected to grow at a CAGR of 14.6% from 2026 to 2032.

Human oocyte cryopreservation (egg freezing) is a procedure to preserve a woman's eggs (oocytes).The eggs are extracted, frozen and stored. The intention of the procedure is that the woman may choose to have the eggs thawed, fertilized, and transferred to the uterus as embryos to facilitate a pregnancy in the future.

America is the largest region market with more than 75% market share in oocyte cryopreservation industry in Canada and USA regions. Top players are Prelude Fertility, CReATe Fertility Center, Anova Fertility, San Diego Fertility Center (SDFC), Extend Fertility, Shady Grove Fertility, Mayo Clinic, Reproductive Biology Associates, CCRM IVF, HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group), Kindbody, West Coast Fertility Centers etc.

The driving factors of the oocyte cryopreservation market mainly include the following aspects:

Technological progress: The continuous improvement and maturity of oocyte cryopreservation technology has improved the recovery rate and survival rate of frozen oocytes, thereby increasing the clinical application prospects of this technology and driving the development of the market.

Changes in fertility concepts: The changes in modern women's fertility concepts and the intensification of the trend of late marriage and late childbearing have led more and more women to choose oocyte cryopreservation technology to maintain fertility and provide guarantees for future fertility plans.

Growth in medical demand: With the improvement of medical standards and people's attention to reproductive health, more and more medical institutions and patients have begun to pay attention to oocyte cryopreservation technology, which has promoted the rapid development of the market.

Policy support: The support policies for assisted reproductive technology in some countries and regions, as well as the improvement of relevant laws and regulations, have provided a good policy environment for the development of oocyte cryopreservation technology.

This report presents a comprehensive overview of the global Oocyte Cryopreservation market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Slow-cooling Method
• Flash-freezing Process (Vitrification)

Segment by Customer

• 25-30 Year Old Female
• 30-35 Year Old Female
• 35-40 Year Old Female
• Others

Segment by players, this report covers

• Prelude Fertility
• CReATe Fertility Center
• Anova Fertility
• San Diego Fertility Center (SDFC)
• Extend Fertility
• Shady Grove Fertility
• Mayo Clinic
• Reproductive Biology Associates
• CCRM IVF
• HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
• Kindbody
• West Coast Fertility Centers
• Ruizhimei

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Oocyte Cryopreservation market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in key end-use industries evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact